NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
107 hedge funds and large institutions have $849M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 21 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
5% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 19
32% less capital invested
Capital invested by funds: $1.25B → $849M (-$401M)
Holders
107
Holding in Top 10
7
Calls
$642K
Puts
$21K
Top Buyers
| 1 | +$18.8M | |
| 2 | +$9.86M | |
| 3 | +$8.63M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$6.75M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.46M |
Top Sellers
| 1 | -$25.8M | |
| 2 | -$16.8M | |
| 3 | -$10.9M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$10.6M |
| 5 |
BlackRock
New York
|
-$9.17M |